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C-reactive protein (CRP) levels were measured using a new
particle-mediated immunoassay. Tests for precision and linearity
of this method gave satisfactory results. The minimum sensitivity
of the assay was 1 ng/ml. Interference by bilirubin (<220mg/l)
and haemoglobin (<20g/l) was not observed. Using this method,
CRP was assayed as a means of monitoring for infection in
newborns up to 72h after delivery. The pattern of time course
elevation curves was similar for both groups (10 healthy subjects
and 26patients), but the serum CRP (ng/ml) of infected newborns
rose significantly higher than in healthy subjects at 24 h after birth.
The rate of increase of CRP (ACRP; ng/ml/h) may be a more
useful parameter to detect infection, since a significant change in
ACRP was apparent only 12 h after birth. The reported method
was reliable and the parameters obtained were considered clinically
usefulfor early detection of infection.
Introduction
with anti-CRP antibody (Ranream-CRP, Toa Medical
Electronics). Most blood cell counters employ an im-
pedance method to measure the number and size of blood
cells, and this principle has been applied to the instru-
ment. Principally, the size and number of aggregates
resulting from a complex between antigen and anti-
body-coated particles are measured through the Coulter
aperture. The reagent kit consists of three solutions: a
buffer solution (maleic acid buffer containing 5% bovine
serum albumin, 50mM, pH 6.0), a latex reagent suspen-
sion specific for CRP, and a diluent (Tris buffer contain-
ing 3% gelatin, pH 7.5) that can be used when the CRP
of the sample is very high. A commercially available
WHO biologic reference sample (CRP No. 85/506) was
used as our standard.
Eighty microlitres of the buffer solution was added to
10 gl of serum or plasma, and the mixture was left for
min. Then, 10 gl of the latex reagent was added to the
above mixture. Fifteen minutes later, the agglutination
that resulted from the antigen-antibody reaction was
measured by PAMIA-30. When the CRP of the sample
was 1000 ng/ml or higher, the sample was diluted auto-
matically with the diluent in the reagent kit.
Three clinical parameters have been used routinely for
the diagnosis of infections in infants: the number of
circulating neutrophils [1]; the serum concentration of
cytokines [2-4]; and the serum concentration of acute
phase proteins, e.g. C-reactive protein (CRP) [5].
Among these, the measurement of CRP is particularly
helpful in diagnosing early bacterial infections [6-12].
However, such measurement in newborns is not as easy as
in infants, due to the difficulty of blood collection and
frequent elevations of CRP. Another reason that CRP is
not always measured in newborns is that the present
methods for CRP determination cannot detect subtle
changes.
A recently developed particle-mediated immunoassay
method [13] can detect various antigens rapidly and
precisely using a specific antibody reagent (Ranream).
Using this method, we evaluated CRP changes for the
early diagnosis of infections in newborns.
Intra- and inter-assay precision
In order to evaluate intra-assay precision, sera with
different CRP concentrations were assayed 10 times,
and a coefficient variation (CV) was calculated for each
serum sample. The same sera were assayed every day for
two weeks, and CV was calculated to evaluate inter-assay
precision.
Sensitivity of the CRP assay
A standard solution of CRP (CRP 10 ng/ml, Toa Med-
ical Electronics) was diluted with Tris buffer (pH 7.5)
containing 3% gelatin to make mixtures with CRP
concentrations of 0.0, 1.0, 2.0, 4.0, 6.0, 8.0 and 10.0ng/
ml. Each mixture was assayed 10 times and {(amount of
polymerized particles) (total amount of anti-CRP coated
particles)} was calculated (P/T). The mean and standard
deviation (SD) was calculated for each mixture.
Subjects and methods
Assay method
Serum CRP was measured using an automated immuno-
assay system, the PAMIA-30 (Toa Medical Electronics,
Kobe, Japan) [13] and a latex particle reagent coated
Linearity
Serum from two patients with high CRP levels (1097 ng/
ml and 192 000 ng/ml) was diluted with Tris buffer
(pH 7.5) containing 3% gelatin. The mean value was
calculated and plotted on a graph.
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Table 1. Intra- and inter-assay precision of CRP determination by counting immunoassay.
Intra-assay (n 10) Interassay (n 14)
Sample Mean (ng/ml) SD(ng/ml) CV (%) Mean (ng/ml) SD(ng/ml) CV (%)
55.7 1.2 2.1 56.2 2.0 3.6
2 275.7 4.0 1.5 279.1 7.7 2.8
3 863.8 31.4 3.6 890.8 32.9 3.7
Effect of bilirubin and haemoglobin on the CRP assay
Bilirubin (28-220mg/1, Interference Check A Plus Bili-
rubin, International Reagents, Kobe, Japan) of haemo-
globin (20-50 g/l, Interference Check A Plus
Haemoglobin, International Reagents) was added to
serum at varying concentrations (n 3), and the CRP
value of each solution was compared with values ob-
tained from the serum without added bilirubin or
haemoglobin.
Comparison of serum and plasma
Plasma obtained from heparinized blood and serum from
the same adults (n 10) were assayed and the results
compared.
Correlation with resultsfrom an automated nephelometric analyser
Serum CRP was assayed with PAMIA-30 and an auto-
mated nephelometry analyser LX3000 (Eiken Chemical,
Tokyo, Japan) for randomly selected samples (n 50).
Subjects
All newborns studied were delivered at term. A diagnosis
of infection was made by clinical findings associated with
fever of greater than 38C after delivery, as well as
tachypnea, apnea, nasal flaring, retractions, cyanosis,
poor skin colour, bradycardia or tachycadia. Cloudy
amniotic fluid or premature rupture of membranes was
also considered to be consistent with infection. Treatment
with antibiotics was initiated for all infected newborns.
Newborns without any signs of infection at birth were
used as the non-infected control group.
The experiments were conducted with permission from
our Institutional Review Board. Attending physicians
obtained informed consent from the newborns’ parents.
CRP assay for non-infected and infected newborns
CRP levels of non-infected (n 10) and infected (n 26)
subjects were studied. Heparinized cord blood was
obtained immediately after birth, and plasma was sepa-
rated by centrifugation. Venous blood specimens were
collected from newborns at 6, 12, 24, 48 and 72 h after
birth, and serum was obtained from clotted blood within
6 h after blood collection.
Statistics
Student’s t-test was used for analysis.
Results
Performance of CRP determination
The intra-assay precision was 1.5-3.6% ofCV, and inter-
assay precision was 2.8-3.7% (table 1).
Mixtures with different CRP concentrations (0.0-
10.0ng/ml) were assayed, and mean and standard devi-
ations of P/T were obtained. The mean +3 SD of P/T of
the mixture with 0.0ng/ml of CRP was 0.368, and this
was lower than the mean -3 SD (0.369) of the mixture
with ng/ml of CRP. Thus, the sensitivity for CRP
determination was judged to be ng/ml (figure 1).
Excellent linearity was demonstrated for both samples
(figure 2). Interference tests revealed bilirubin (<220 mg/
1) and haemoglobin (<20g/l) did not interfere with
the measurement. CRP of serum (1206-t-1579) and
plasma (1163:5 1597) from the same adults were not
significantly different (r 0.994, y 1.008x- 52.69,
n 10). The serum CRP measured by the present
method correlated well with those assayed by the auto-
mated nephelometry analyser LX3000 (figure 3).
CRP levels in non-infected and infected newborns
No difference was observed in CRP levels between cord
blood and venous blood taken immediately after birth in
both infected and non-infected groups. Most individual
CRP levels were less than 100 ng/ml in both. The time
course of CRP in non-infected (healthy) newborns
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Figure 1. Sensitivity of the CRP assay, x-axis shows concentra-
tions of CRP and the y-axis is P/T, calculated as { (amount of
polymerized particles)/(total amount of anti-CRP coated par-
ticles) }. The open circle and bars for each concentration are the
means + 3 standard deviation.
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Figure 2. Linearity; two serum samples were diluted and the
CRP levels were plotted.
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Figure 3. Correlation with an automated nephelometry analyser
LX3000.
showed an increasing trend, reaching a maximum level
by 24h after birth, and decreasing at 48h (table 2).
Infected newborns also had increasing levels. No signifi-
cant differences were seen between non-infected and
infected groups up to 12 h after delivery. At 24, 48 and
72 h, CRP was significantly higher in infected newborns
than in non-infected newborns.
When the ACRP (ng/ml/h)’ was calculated for both
groups, a significant difference was observed between
the two at 12 h.
Discussion
The clinical utility of CRP as a marker of inflammation
has increased due to precise and accurate measurements
now possible with sophisticated technology, e.g. the latex
particle immunoassay (LPIA) [8-10], the turbidimetric
immunoassay (TIA) [5] and the radioimmunoassay
(RIA) [11, 12]. These methods can determine precise
levels of CRP between 50 and 5000ng/ml, but cannot
detect minor changes at lower concentrations. As a
means of improving the early diagnosis and treatment
of acute infection, PAMIA-30 was developed for routine
clinical use.
When compared to other methods, PAMIA-30 has sev-
eral advantages. The volume necessary for an assay is
40 gl, including the dead volume of 30 lal. Because it is
often difficult to get enough blood for CRP assays, the
advantage of PAMIA here is clearly substantial. The
results can also be obtained in 15 min. Linear determina-
tion up to 200 000 ng/ml of CRP was possible. When the
CRP of the samples is 1000 ng/ml or more, the PAMIA
can select the dilution ratio, dilute the sample, and assay
it again automatically. Both in infected and non-infected
groups, the CRP level in cord blood was very low, with
the CRP of two-thirds of the samples lower than 50 ng/ml
in this study. With this method, such low concentrations
of CRP and their changes could be detected. The results
of precision tests also were satisfactory.
White blood cell counts represent an easy way to detect
infection, but the white cell count usually increases after
the CRP increases. Cytokines, e.g. IL-6, can also serve as
a marker of infection, but they are usually limited to
experimental use due to high reagent costs. Buck et al. [2]
have reported that the measurement of IL-6 is more
useful for the diagnosis of infection in infants than the
measurement of CRP, and that the measurement of
IL-6 levels at 24h after birth contribute to the clinical
diagnosis of infection. However, this measurement is not
used very widely; measuring CRP is more practical,
convenient and economical. Our data demonstrate that
Table 2. Time course of serum CRP and ACRP levels after delivery.
Time after delivery (h)
Newborns 0 6 12 24 48 72
CRP Non-infected
(ng/ml) (n= 10)
Infected
ACRP Non-infected
(ng/ml/h) (n 10)
Infected
(n 26)
59.1 +/- 16.4 104.5 4- 28.6
53.8 4- 10.1 265.7 +/- 151.3
405.3-+-81.5 1268.1 +492.8 1117.54-359.0 956.6+/- 150.0
6713.0-+-2987.0 8331.24-2334.8"* 10504 4-2907.5** 4417.8 4- 1008.8"*
4.7 4- 5.3 34.5 zt: 9.6 50.8 4- 26.1 29.8 4- 8.5 15.1 4- 2.9
58.2 4- 35.9 548.9 4- 230.5* 395.9 4- 114.2"* 306.5 4- 94.7** 68.7 4- 16.1"*
Each value shows mean 4- 1SE, * P < 0.05, ** P < 0.001.
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CRP monitoring is very helpful for diagnosing infection,
because large increases are sufficiently more likely to
occur in cases of newborn infection than in healthy
infants. Serial observation of CRP was both sensitive
and reproductible, and detection of subtle changes with
a minimum amount of blood was possible. When using
CRP concentration as a parameter for diagnosis, a sig-
nificant difference was observed between infected and
non-infected groups at 24 h after delivery, and no subject
in the non-infected group showed a CRP of3000 ng/ml or
higher. The ACRP (ng/ml/h) could be a better par-
ameter, since a significant difference was found at 12 h.
Also, a threshold of about 70ACRP (ng/ml/h) could
differentiate an infected from a non-infected newborn,
with a sensitivity [true positive/ (true positive+false
negative)] of 69.9% and specificity [true negative/ (true
negative + false positive)] of 100%. Thus, this fully auto-
mated, non-isotopic method should be clinically useihl
for early detection of infection in newborns.
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